Low-dose doxycycline inhibits hydrogen peroxide-induced oxidative stress, MMP-2 up-regulation and contractile dysfunction in human saphenous vein grafts

References

• Al-Sabti HA, Al Kindi A, Al-Rasadi K, Banerjee Y, Al-Hashmi K, Al-Hinai A. Saphenous vein graft vs. radial artery graft searching for the best second coronary artery bypass graft. J Saudi Heart Assoc. 2013;25(4):247–254. doi:10.1016/j.jsha.2013.06.00124198449
   PubMedGoogle Scholar
• Wadey K, Lopes J, Bendeck M, George S. Role of smooth muscle cells in coronary artery bypass grafting failure. Cardiovasc Res. 2018;114(4):601–610. doi:10.1093/cvr/cvy02129373656
   PubMed Web of Science ®Google Scholar
• Day J, Taylor K. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg. 2005;3(2):129–140. doi:10.1016/j.ijsu.2005.04.00217462274
   PubMedGoogle Scholar
• Zakkar M, Guida G, Suleiman M, Angelini GD. Cardiopulmonary bypass and oxidative stress. Oxid Med Cell Longev. 2015;2:1–8. doi:10.1155/2015/189863
   Web of Science ®Google Scholar
• Orhan G, Yapici N, Yuksel M, et al. Effects of N-acetylcysteine on myocardial ischemia–reperfusion injury in bypass surgery. Heart Vessels. 2006;21(1):42–47. doi:10.1007/s00380-005-0873-116440148
   PubMed Web of Science ®Google Scholar
• Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562–573. doi:10.1016/j.cardiores.2005.12.00216405877
   PubMed Web of Science ®Google Scholar
• Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 2005;85(1):1–31. doi:10.1152/physrev.00048.200315618476
   PubMed Web of Science ®Google Scholar
• Bench TJ, Jeremias A, Brown DL. Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease. Pharmacol Res. 2011;64(6):561–566. doi:10.1016/j.phrs.2011.05.00221624471
   PubMed Web of Science ®Google Scholar
• Benjamin MM, Khalil RA. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease. EXS. 2012;103:209–279. doi:10.1007/978-3-0348-0364-9_722642194
   PubMedGoogle Scholar
• Newby AC. Metalloproteinases promote plaque rupture and myocardial infarction: a persuasive concept waiting for clinical translation. Matrix Biol. 2015;44:157–166. doi:10.1016/j.matbio.2015.01.01525636537
   PubMed Web of Science ®Google Scholar
• Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368(21):2004–2013. doi:10.1056/NEJMra121606323697515
   PubMed Web of Science ®Google Scholar
• Quillard T, Tesmenitsky Y, Croce K, et al. Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31(11):2464–2472. doi:10.1007/s12012-013-9231-121903941
   PubMed Web of Science ®Google Scholar
• Golub L, Lee H-M, Ryan M, Giannobile W, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res. 1998;12(1):12–26. doi:10.1177/089593749801200105019972117
   PubMedGoogle Scholar
• Peterson JT. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail Rev. 2004;9(1):63–79. doi:10.1023/B:HREV.0000011395.11179.af14739769
   PubMed Web of Science ®Google Scholar
• Golledge J, Norman PE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis. 2011;217(1):57–63. doi:10.1016/j.atherosclerosis.2011.03.00621596379
   PubMed Web of Science ®Google Scholar
• Villarreal FJ, Griffin M, Omens J, Dillmann W, Nguyen J, Covell J. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation. 2003;108(12):1487–1492. doi:10.1161/01.CIR.0000089090.05757.3412952845
   PubMed Web of Science ®Google Scholar
• Kormi I, Alfakry H, Tervahartiala T, Pussinen PJ, Sinisalo J, Sorsa T. The effect of prolonged systemic doxycycline therapy on serum tissue degrading proteinases in coronary bypass patients: a randomized, double-masked, placebo-controlled clinical trial. Inflamm Res. 2014;63(5):329–334. doi:10.1007/s00011-013-0704-224378958
   PubMed Web of Science ®Google Scholar
• Cerisano G, Buonamici P, Gori AM, et al. Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial. Int J Cardiol. 2015;197:147–153. doi:10.1016/j.ijcard.2015.06.02426134371
   PubMed Web of Science ®Google Scholar
• Castro MM, Rizzi E, Ceron CS, et al. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide. 2012;26(3):162–168. doi:10.1016/j.niox.2012.01.00922327038
   PubMed Web of Science ®Google Scholar
• Antonio RC, Ceron CS, Rizzi E, Coelho EB, Tanus-Santos JE, Gerlach RF. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR. Mol Cell Biochem. 2014;386(1–2):99–105. doi:10.1007/s11010-013-1848-724114660
   PubMed Web of Science ®Google Scholar
• Zeydanli EN, Kandilci HB, Turan B. Doxycycline ameliorates vascular endothelial and contractile dysfunction in the thoracic aorta of diabetic rats. Cardiovasc Toxicol. 2011;11(2):134–147. doi:10.1007/s12012-011-9107-121360312
   PubMed Web of Science ®Google Scholar
• Ozcinar E, Okatan EN, Tuncay E, Eryilmaz S, Turan B. Improvement of functional recovery of donor heart following cold static storage with doxycycline cardioplegia. Cardiovasc Toxicol. 2014;14(1):64–73. doi:10.1007/s12012-013-9231-124104944
   PubMed Web of Science ®Google Scholar
• Banerjee D, Madhusoodanan UK, Nayak S, Jacob J. Urinary hydrogen peroxide: a probable marker of oxidative stress in malignancy. Clin Chim Acta. 2003;334(1–2):205–209. doi:10.1016/S0009-8981(03)00236-512867293
   PubMed Web of Science ®Google Scholar
• Lacy F, Kailasam MT, O’Connor DT, Schmid-Schonbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension (Dallas, Tex: 1979). 2000;36(5):878–884.
   PubMed Web of Science ®Google Scholar
• Hummitzsch L, Zitta K, Berndt R, et al. Doxycycline protects human intestinal cells from hypoxia/reoxygenation injury: implications from an in-vitro hypoxia model. Exp Cell Res. 2017;353(2):109–114. doi:10.1016/j.yexcr.2017.03.01728300560
   PubMed Web of Science ®Google Scholar
• Gokce G, Arun M. Ergothioneine produces relaxation in isolated rat aorta by inactivating superoxide anion. Eur Rev Med Pharmacol Sci. 2014;18(21):3339–3345.25487948
   PubMed Web of Science ®Google Scholar
• Guzeloglu M, Reel B, Atmaca S, Bagrıyanık A, Hazan E. The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model. J Cardiothorac Surg. 2012;57(7):1–8. doi:10.1186/1749-8090-7-57
   Web of Science ®Google Scholar
• Ogut D, Reel B, Korkmaz CG, Arun MZ, Micili SC, Ergur BU. Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-κB signaling in LPS-induced PC3 cells. Folia Histochem Cytobiol. 2016;54(4):171–180. doi:10.5603/FHC.a2016.002227966209
   PubMed Web of Science ®Google Scholar
• Castro MM, Rizzi E, Figueiredo-Lopes L, et al. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis. 2008;198(2):320–331. doi:10.1016/j.atherosclerosis.2007.10.01118054360
   PubMed Web of Science ®Google Scholar
• Newby AC. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res. 2006;69(3):614–624. doi:10.1016/j.cardiores.2005.08.00216266693
   PubMed Web of Science ®Google Scholar
• Kelly PJ, Morrow JD, Ning M, et al. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke. 2008;39(1):100–104. doi:10.1161/STROKEAHA.107.48818918063832
   PubMed Web of Science ®Google Scholar
• Arun MZ, Reel B, Sala-Newby GB, et al. Zoledronate upregulates MMP-9 and -13 in rat vascular smooth muscle cells by inducing oxidative stress. Drug Des Devel Ther. 2016;10:1453–1460. doi:10.2147/DDDT.S103124
   PubMed Web of Science ®Google Scholar
• Yu M, Chen C, Cao Y, Qi R. Inhibitory effects of doxycycline on the onset and progression of abdominal aortic aneurysm and its related mechanisms. Eur J Pharmacol. 2017;811:101–109. doi:10.1016/j.ejphar.2017.05.04128545777
   PubMed Web of Science ®Google Scholar
• Lee -H-H, Lin T-H, Su H-M, et al. Recurrent thrombosis in a case of coronary ectasia with large thrombus burden successfully treated by adjunctive warfarin therapy. Acta Cardiol Sin. 2013;29(5):462–466.27122745
   PubMed Web of Science ®Google Scholar
• Katsu M, Niizuma K, Yoshioka H, Okami N, Sakata H, Chan PH. Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood–brain barrier dysfunction in vivo. J Cereb Blood Flow Metab. 2010;30(12):1939–1950. doi:10.1038/jcbfm.2010.4520354546
   PubMed Web of Science ®Google Scholar
• Burke TM, Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol Heart Circ Physiol. 1987;252(4):H721–H732. doi:10.1152/ajpheart.1987.252.4.H721
   Web of Science ®Google Scholar
• Barlow RS, White RE. Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am J Physiol Heart Circ Physiol. 1998;275(4):H1283–H1289. doi:10.1152/ajpheart.1998.275.4.H1283
   Web of Science ®Google Scholar
• Chew DK, Conte MS, Khalil RA. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction. J Vasc Surg. 2004;40(5):1001–1010. doi:10.1016/j.jvs.2004.08.03515557917
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Ross RL, Khalil RA. Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation. J Vasc Surg. 2007;45(2):373–380. doi:10.1016/j.jvs.2006.10.04117264019
   PubMed Web of Science ®Google Scholar
• Waitkus-Edwards KR, Martinez-Lemus LA, Wu X, et al. α4β1 Integrin activation of L-type calcium channels in vascular smooth muscle causes arteriole vasoconstriction. Circ Res. 2002;90(4):473–480. doi:10.1161/hh0402.10589911884378
   PubMed Web of Science ®Google Scholar
• Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev. 2001;53(2):245–282.11356985
   PubMed Web of Science ®Google Scholar
• Cena JJ, Lalu MM, Cho WJ, et al. Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia. Am J Physiol Heart Circ Physiol. 2009;298(1):H45–H51. doi:10.1152/ajpheart.00273.200919837953
   PubMed Web of Science ®Google Scholar
• Castro MM, Cena J, Cho WJ, Walsh MP, Schulz R. Matrix metalloproteinase-2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats. Arterioscler Thromb Vasc Biol. 2012;32(3):662–668. doi:10.1161/ATVBAHA.111.24268522199370
   PubMed Web of Science ®Google Scholar
• Pires PW, Rogers CT, McClain JL, Garver HS, Fink GD, Dorrance AM. Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2011;301(1):H87–H97. doi:10.1152/ajpheart.01206.201021551278
   PubMed Web of Science ®Google Scholar